Wockhardt informs about press release

16 Oct 2024 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed a Press Release titled ‘Wockhardt files fast-acting Insulin Aspart injection (ASPARAPIDTM) with DCGI; strengthens commitment to diabetes management’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1374.50 24.15 (1.79%)
22-Jan-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1641.90
Dr. Reddys Lab 1215.45
Cipla 1380.65
Zydus Lifesciences 886.70
Lupin 2183.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×